Delivery Order SPE2DB20D9331-SPE2DB24FL0Q0

Award Date 2/6/24
Potential Completion Date 2/28/24
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $18,526.83 under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The contract, which runs through December 31, 2025, is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $1,269.83 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The award, with a completion date of September 16, 2024, is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. DMS Pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract covers a wide range of pharmaceutical products, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under a larger indefinite delivery contract (SPE2DB) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The order, worth $37,422.87, is for a wide range of pharmaceutical products and medical supplies to support the recurring needs of military health facilities worldwide. DMS Pharmaceutical Group specializes in providing branded and generic prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) valued at $499,999,999. The contract covers the provision of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides the Defense Logistics Agency (DLA) with a wide range of pharmaceutical products and medical supplies. The contract, valued at up to $57,317.20, is a firm fixed-price delivery order with no set-aside designation. The contract covers a comprehensive array of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program, which is a single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999. The contract covers the supply of a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract valued at up to $499,999,999. The contract, with a ceiling value of $18,526.83 and a completion date of October 3, 2024, is for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The order, valued at $11,006.95, is for the provision of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical centers nationwide....
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB24FL0Q0
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order worth $21,274.80 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract runs through February 28, 2024, and covers the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical needs of military healthcare facilities worldwide.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. This contract, along with the company's other prime vendor agreements for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites, solidifies DMS Pharmaceutical Group's role as a crucial supplier in the federal pharmaceutical supply chain.

Generated 1/9/25, 9:32 AM